CHEN YOUNG: Open Payments
NPI 1164465746 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$577 in 21 payments from 9 companies in 2025. Trend: 2023 $322 · 2024 $911 · 2025 $577
Food & beverage: $577
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $239 |
| ABBVIE INC. | 4 | $80 |
| Novo Nordisk Inc | 3 | $58 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| PFIZER INC. | 2 | $42 |
| Exact Sciences Corporation | 1 | $30 |
| Hologic Sales and Service, LLC | 1 | $24 |
| Lilly USA, LLC | 1 | $17 |
Products named: BREZTRI, UBRELVY, SHINGRIX, Ozempic, The Cologuard Plus Collection Kit, QULIPTA, APTIMA, PAXLOVID.
Industry payments across TX — which companies pay providers there.
